Shanghai Pharmaceuticals Holding Co Ltd (SHPMY)
7.915
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Shanghai Pharmaceuticals Total Liabilities (Quarterly): 19.02B for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 19.02B |
| December 31, 2023 | 18.57B |
| September 30, 2023 | 18.23B |
| June 30, 2023 | 18.52B |
| June 30, 2023 | 18.52B |
| March 31, 2023 | 18.33B |
| December 31, 2022 | 17.41B |
| September 30, 2022 | 16.56B |
| June 30, 2022 | 16.63B |
| June 30, 2022 | 16.63B |
| March 31, 2022 | 16.93B |
| December 31, 2021 | 16.37B |
| September 30, 2021 | 16.25B |
| June 30, 2021 | 15.64B |
| June 30, 2021 | 15.64B |
| March 31, 2021 | 15.09B |
| December 31, 2020 | 14.46B |
| September 30, 2020 | 13.98B |
| June 30, 2020 | 13.56B |
| June 30, 2020 | 13.56B |
| March 31, 2020 | 12.64B |
| December 31, 2019 | 12.53B |
| September 30, 2019 | 12.19B |
| June 30, 2019 | 12.50B |
| June 30, 2019 | 12.50B |
| Date | Value |
|---|---|
| March 31, 2019 | 12.88B |
| December 31, 2018 | 11.69B |
| September 30, 2018 | 11.45B |
| June 30, 2018 | 11.31B |
| June 30, 2018 | 11.31B |
| March 31, 2018 | 11.17B |
| December 31, 2017 | 8.374B |
| September 30, 2017 | 7.962B |
| June 30, 2017 | 7.763B |
| June 30, 2017 | 7.763B |
| March 31, 2017 | 7.394B |
| December 31, 2016 | 6.610B |
| September 30, 2016 | 6.746B |
| June 30, 2016 | 6.622B |
| June 30, 2016 | 6.622B |
| March 31, 2016 | 6.612B |
| December 31, 2015 | 6.244B |
| September 30, 2015 | 6.250B |
| June 30, 2015 | 6.105B |
| June 30, 2015 | 6.105B |
| March 31, 2015 | 5.694B |
| December 31, 2014 | 5.359B |
| September 30, 2014 | 5.584B |
| June 30, 2014 | 5.363B |
| June 30, 2014 | 5.363B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
12.19B
Minimum
Sep 2019
19.02B
Maximum
Mar 2024
15.69B
Average
16.25B
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 1.635B |
| CASI Pharmaceuticals Inc | 51.10M |
| Zai Lab Ltd | 226.27M |
| Gracell Biotechnologies Inc (DELISTED) | 36.85M |
| Adagene Inc | 45.17M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 30.55B |
| Shareholders Equity (Quarterly) | 9.845B |
| Debt to Equity Ratio | 0.6794 |
| Current Ratio | 1.336 |
| Net Debt Paydown Yield | -4.78% |